ELF SANOFI, BAYER AG ANNOUNCE INTEREST IN BIDDING FOR STERLING OTC COMPONENTS
This article was originally published in The Tan Sheet
Executive Summary
ELF SANOFI, BAYER AG ANNOUNCE INTEREST IN BIDDING FOR STERLING OTC COMPONENTS in statements released shortly after Eastman Kodak's May 3 announcement that it is seeking buyers for its Sterling Winthrop prescription and OTC businesses. Sanofi is interested in purchasing Sterling's European prescription and OTC businesses, which it already manages under a 1991 alliance with Sterling. Bayer emphasized its interest in expanding its U.S. OTC business.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning